International Impact of Vaccine Safety Concerns Learning the hard way for 20 years.

Slides:



Advertisements
Similar presentations
The Vaccine Adverse Event Reporting System: A Tool for Safety and Surveillance Jane Woo, MD, MPH Vaccine Safety Branch Division of Epidemiology Office.
Advertisements

Module 6 Rotavirus vaccine AEFI monitoring
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Risk Perception The fundamental dilemma of health risk communication  The risks that kill people and the risks that alarm people are completely different.
ECONOMIC ASPECTS OF COMBINED VACCINES Malta, October 2001 Philippe Beutels Centre for the Evaluation of Vaccination WHO collaborating centre for.
The answer to the question: What is it? Home based business where you can make money part time without jeopardizing what your currently doing, so that.
Extension Article by Dr Tim Kenny
Vaccine Safety Elizabeth Tatum Draper RN Clinical Consultant North Carolina Immunization Branch July 2011.
HIV Clinical Trials Janice Price, M.Ed, RN HIV Clinical Research Program Coordinator Swedish Medical Center Seattle, WA USA.
Use of Children as Research Subjects What information should be provided for an FP7 ethical review?
DRUG SAFETY RESEARCH June 16, ISSUES Pharmaceutical Industry Depends on Block Buster Model (currently ~80 BBs). Block Buster Model requires fast.
How often do I fool myself or get fooled by others? A.Almost never B.Rarely C.More often than I’d like… D.Other This is an opinion question. Two points.
IMMUNIZATIONS HEALTHROOM ASSISTANT TRAINING Cheri Dotson, RN, BSN, MA
Module 6 Inactivated poliovirus vaccine AEFI monitoring Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Prepared by : 1) Ahmed Ehab El-Bitar 2) Yahya Awaad Badran 3) Suliman Tariq Suliman 4) Mohammed El-Sayed Fath El-bab 5)
LESSON 5.7: VACCINATIONS Module 5: Public Health Obj. 5.1: Evaluate the potential consequences of the anti-vaccination movement.
Track A: Basic Science This track highlighted all aspects of HIV structure, replication, and the host immune responses and led to a greater understanding.
Working toward the good of the community without the expense of others.
Your Child's Best Shot A parent's guide to vaccination.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
Social Science, Public Engagement and Genetic Databases: Lessons from Generation Scotland Sarah Cunningham-Burley and Gill Haddow University of Edinburgh.
Vaccines.  Learning Intention:  Today we are learning and exploring the importance of vaccines on our and the community’s health.  Success Criteria:
DrugEpi 5-5 Policy Question: Medical Marijuana Module 5 Overview Context Content Area: Policy Decisions about Drug Use/Abuse Issues Essential Question.
Respond Detect Report Investigate Adverse Events Following Immunization Dr S.M.Zahraei Center for Disease Control Ministry of Health and Medical Education.
Issues Involving Public Perception: The Negative Case George J. Agich, Ph.D. F. J. O'Neill Chair in Clinical Bioethics Chairman, Department of Bioethics.
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
HIV/AIDS VACCINE AWARENESS Vaccine 101 Jeremiah Brewer Health and Training Educator African – Americans Reach and Teach Health Ministry.
6.3 Ethics in Statistics. Minimizing Risk vs. Maximizing Info To test a new surgical practice, should you account for the placebo effect by performing.
“Countering the antivaccination movement and vaccination scares - Working with the Media” VHPB – Geneva Robert Aston, UK 14 March 2003.
MEDICAL INNOVATION March What Are The Public Health Benefits of Medical Innovation? Breakthrough medicines New devices Innovative medical procedures.
New Vaccine Supply and Financing: A Case Study of Combination Vaccines in Developing Countries Viral Hepatitis Prevention Board Meeting Malta October 22-23,
Ezekial Emanual, Chief of Bioethics NIH Simple idea: justice requires treating everyone, everywhere in exactly the same way Justice requires no such thing.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Immunization Safety Review: Vaccines and Autism Marie McCormick Chair, Immunization Safety Review Committee Presentation to NVAC June 2004.
DEVELOPING EVIDENCE ON VACCINE SAFETY Susan S. Ellenberg, Ph.D. Center for Clinical Epidemiology and Biostatistics U Penn School of Medicine Global Vaccines.
Immunity 6.6 Vaccination.
4. Access to medication & healthcare Learning objectives: - to identify the why many people cannot access medication - to understand how NGOs and the UN.
What about vaccinations? Give valid information to show the benefits of vaccinating Disprove any false information or resources.
Chapter 1 Introduction to Wilderness First Aid. Lesson Objectives (1 of 2) Define wilderness. Compare wilderness first aid to traditional first aid. Identify.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
1 Clinical trials with stem cells Bernard Lo, M.D. February 12, 2009.
Good Science vs. Bad Science H. Smith. Terminology Hypothesis: statement which predicts what will happen – Ex: If I drop this beaker, then it will break.
Relating to the Public.
Thomas Weiser, MD, MPH Medical Epidemiologist Portland Area Indian Health Service Northwest Portland Area Indian Health Board.
By Brandon Huddleston PHE 326 Winter Term  Vaccine - A vaccine is any preparation intended to produce immunity to a disease by stimulating the.
Literature Search Perform a thorough literature review, even if it means having to understand several different areas. You don't want to find out after.
HIV/AIDS Summary of Questions. What is HIV? Human immunodeficiency virus (remember, no official scientific name for viruses) Human immunodeficiency virus.
Your decision  Last lesson you attended a public enquiry meeting about the use of Orgreave mine as a landfill site.  Fill in the opinion pole sheet to.
Immunisation Part2 Schedule (part 1) Reason for doing it (part 2) Why some don’t do it. (part 2)
Ethics of Research. History of Regulation of Research n A history of scandals –Nazi experiments, WWII –Beecher expose of US research without consent,
A quick overview into current uses of the emerging big data technologies within the industry Basel Life Sciences Forum 18JUN2015 Rob Walls EU Regional.
Module 7 Communicating with parents, caregivers and health personnel about IPV and multiple injections Training for Inactivated Poliovirus Vaccine (IPV)
UNIT 5 Perceptions of Science
1. Girls in England & Wales who are in year 8, are being offered a vaccine to help protect them against Human Papilloma Virus, or HPV, the main cause.
Equipping the Next Generation for Active Engagement in Science EngagingScience.eu שילוב נושאים סוציו-מדעיים ואתיים בלימודי מדע ד"ר יעל שורץ, אתי דגן ואמיל.
BOOK DISCUSSION Michelle Eberle Education & Outreach Coordinator National Network of Libraries of Medicine, New England Region.
Understanding Epidemiology Introduction to Epidemiology and Epidemiological Concepts.
Lesson #11: Ethics. What are ethics as they pertain to experiments??? O Is it ethical to conduct animal testing? O Is it ethical to distribute placebo.
Why Should You Get Vaccinated?
National Immunization Conference April 19, 2010
Methods of Science Lesson 1 Understanding Science
Khine Zaw Oo Defence Services Medical Research Centre Myanmar
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Learning Targets for Introduction to Physics
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Presentation transcript:

International Impact of Vaccine Safety Concerns Learning the hard way for 20 years

Lessons from the plasma derived HB vaccine “This vaccine may be crawling with AIDS virus…” The concern was quickly addressed scientifically but public never heard this The issue of safety of plasma derived vaccine never went away (but the vaccine did) seriously delayed HB introduction in many countries exploited by industry for marketing purposes

First big lesson Many of these issues will never go away will have to be managed like a chronic illness with periodic flare-ups It is much easier to break an egg than to put a broken egg back together

Bad stuff happens –children die from vaccines and programmatic mistakes Increasing energy and resources go into dealing with anti-vaccination ideas anti-vaccination ideas cross borders –may follow linguistic boundaries –medical leaders trained abroad –influenced by training but often out of date local ideas may generate problems Philippines and sterilization from TT More lessons

Anti-vaccination groups and individuals extremely diverse parents with legitimate concerns religious (pork, fetal tissue, “if God wanted…”) “alternative medicine”, granola types conspiracy theories (sterilization, HIV) “the government can’t tell me what to do” lawyers and others with financial or political agendas scientists who report hypotheses in media opinionated media

What happens in industrial countries has ramifications in developing countries –OPV –thimerosol: huge implications –acellular pertussis –rotavirus IOM is part of the problem: There are insufficient data to confirm or deny an association……. Good news is of little interest to media –scientific hypotheses may take years to confirm or deny, media wants answers in 20 minutes More lessons

Pharmaceutical companies implying competing vaccines are unsafe: a losing strategy for everyone Clinical trials can trigger anti-vacc ideas –Guinea pigs –ethical dilemmas –political agendas (HEV Nepal, HB St. Kitts) Real issues such as unsafe injections arouse little interest

Injection Safety ~16 billion injections/year ~33% unsafe in developing countries ~20 million HBV infections/yr + ~2 million HCV and ~260,000 HIV infections Little change until GAVI and SIGN Fund eligible countries get auto-disable syringes for 3 years. 200 million already distributed Countries responsible for national plan, training, waste management Major GAVI gift to wider HC community

Shifting sands of causality Belief: MMR causes autism (Hx 1) it is antigen #1 DATA OK maybe its not antigen#1, its (Hx 2) giving the antigens together DATA OK maybe its not giving antigens together (Hx 3) it’s the preservative

Nocebo effect If a positive belief in the effectiveness of a therapy can have positive effects (placebo effect ~ 30%), can a negative belief in the safety of a therapy have negative effects? look at France

13 step recovery program No vaccine is 100% effective all vaccines have side effects decision to use or not use based on considering balance between benefits and risks (and on cost effectiveness) disease burden before immunization known risk of vaccine benefit/risk ratio hugely in favor of vaccines

13 step recovery program diseases do return when immunization stops surveillance systems for adverse events by in large work and are able to pick up even rare events research is done to investigate hypotheses of safety problems vaccines are removed or changed when safety concerns are found to be valid

13 step recovery program there are many (chronic diseases) of unknown etiology where vaccines are one of many possible causes we do not stop immunization while we investigate each hypothesis inform where to go for more (reliable) information

What to do become familiar with the issues media training cultivate media leaders know where to get helpful information call for help in investigating local incidents